Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD)

Journal of Clinical Gastroenterology

Volumn 40, Issue 10, 2006, Pages 930-935

  Madan, Kaushal ^a   Bhardwaj, Payal ^a   Thareja, Sandeep ^a   Gupta, Siddhartha D ^a   Saraya, Anoop ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Lipid peroxidation; Nonalcoholic fatty liver disease; Oxidative stress; Total antioxidant capacity

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; FERROUS ION; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANALYTIC METHOD; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HISTOLOGY; HUMAN; LIPID PEROXIDATION; MALE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PRIORITY JOURNAL; VIRUS HEPATITIS; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANTIOXIDANTS; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INDIA; IRON-BINDING PROTEINS; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 33750616470     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000212608.59090.08     Document Type: Article

References (46)

1. Madan K, Batra Y, Panda SK, et al. Role of polymerase chain reaction and liver biopsy in the evaluation of patients with asymptomatic transaminitis: implications in diagnostic approach. J Gastroenterol Hepatol. 2004;19:1291-1299.
2. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413-1419.
3. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134-140.
4. Singh SP, Nayak S, Swain M, et al. Prevalence of non alcoholic fatty liver disease in coastal Eastern India: a preliminary ultrasonographic survey. Trop Gastroenterol. 2004;25:76-79.
5. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98:960-967.
6. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2003;124:71-79.
7. Day CP, James OFW. Steatohepatitis: a tale of two hits? Gastroenterology. 1998;114:842-845.
8. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844-1850.
9. Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 2002;35:373-379.
10. Diehl AM. Nonalcoholic steatohepatitis. Sem Liver Dis. 1999;19:221-229.
11. Kaplowitz N. Mechanisms of liver cell injury. J Hepatol. 2000;32:39-47.
12. Yang SQ, Zhu H, Li Y, et al. Mitochondrial adaptations to obesity related oxidant stress. Arch Biochem Biophys. 2000;378:259-268.
13. Letteron P, Fromenty B, terris B, et al. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol. 1996;24:200-208.
14. Weltman MD, Farrell GC, Hall P, et al. Hepatic cytochrome P 450 2E1 is increased in patients with non alcoholic steatohepatitis. Hepatology. 1998;27:128-133.
15. Loguercio C, De Girolamo V, de Sio I, et al. Nonalcoholic fatty liver disease in an area of southern Italy: main clinical, histological and pathophysiological aspects. J Hepatology. 2001;35:568-574.
16. Harrison SA, Torgerson S, Hayashi P, et al. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepaitis. Am J Gastroenterol. 2003;98:2485-2490.
17. Albano E, Mottaran E, Vidali M, et al. Immune response towards lipid peroxidation products as a perdictor of progression of non alcoholic fatty liver disease to advanced fibrosis. Gut. 2005;54:987-993.
18. Yesilova Z, Yaman H, Oktenli C, et al. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 2005;100:850-855.
19. Nobili V, Pastore A, Gaeta LM, et al. Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis. Clin Chim Acta. 2005;355:105-111.
20. Panigrahi AK, Nanada SK, Dixit RK, et al. Diagnosis of hepatitis C virusassociated chronic liver disease in India: comparison of HCV antibody assay with a polymerase chian reaction for the 5′ noncoding region. J Med Virol. 1994;44:176-179.
21. Stacy DL, Han P. Serum ferritin measurement and the degree of agreement using four techniques. Am J Clin Pathol. 1992;98:511-515.
22. Abe A, Yamashita S, noma A. Sensitive, direct colorimetric assay for copper in serum. Clin Chem. 1989;35:552-554.
23. Norman MR, Mowat AP, Hutchison DC. Molecular basis, clinical consequences and diagnosis of alpha-1-antitrypsin deficiency. Ann Clin Biochem. 1997;34:230-246.
24. Brunt EM, Janney CJ, Di Bisceglie AM, et al. Non-alcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467-2474.
25. Belch JJF, Bridges AB, Scott N, et al. Oxygen free radicals and congestive heart failure. Br Heart J. 1991;65:215-218.
26. Okamura M. An improved method for determination of L-ascorbic acid and L-dehydroascorbic acid in blood plasma. Clin Chem Acta. 1980;103:259-268.
27. Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996;239:70-76.
28. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Non-alcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120:1183-1192.
29. Videla LA, Rodrigo R, Orellana M, et al. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci. 2004;106:261-268.
30. Koruk M, Taysi S, Savas MC, et al. Oxidative stress and enzymatic status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci. 2004;34:57-62.
31. Kampa M, Nistikaki A, Tsaousis V, et al. A new automated method for the determination of the total anitoxidant capacity (TAC) of human plasma, based on the crocin bleaching assay. BMC Clin Pathol. 2002;2:3.
32. Santamaria E, Avila MA, Latasa MU, et al. Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc Natl Acad Sci USA. 2003;100:3065-3070.
33. May JM, Qu ZC, Cobb CE. Human erythrocyte recycling of ascorbic acid: relative contributions from the ascorbate free radical and dehydroascorbic acid. J Biol Chem. 2004;279:14975-14982.
34. Adachi T, Ohta H, Yamada H, et al. Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibody. Clin Chim Acta. 1992;212:89-102.
35. Adachi T, Nakamura M, Yamada H, et al. Quantitative and qualitative changes of extracellular-superoxide dismutase in patients with various diseases. Clin Chim Acta. 1994;229:123-131.
36. Kimura F, Hasegawa G, Obayashi H, et al. Serum extracellular superoxide dismutase in patients with type 2 diabetes. Diabetes Care. 2003;26:1246-1250.
37. Adachi T, Ohta H, Hirano K, et al. Non-enzymic glycation of human extracellular superoxide dismutase. Biochem J. 1991;279:263-267.
38. Akalin FA, Toklu E, Renda N. Analysis of superoxide dismutase activity levels in gingiva and gingival crevicular fluid in patients with chronic periodontitis and periodontally healthy controls. J Clin Periodontol. 2005;32:238-243.
39. Raho G, Cassano N, D'Argento V, et al. Over-expression of Mn-superoxide dismutase as a marker of oxidative stress in lesional skin of chronic idiopathic urticaria. Clin Exp Dermatol. 2003;28:318-320.
40. Laybutt DR, Kaneto H, Hasenkamp W, et al. Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to beta-cell survival during chronic hyperglycemia. Diabetes. 2002;51:413-423.
41. Broide E, Klinowski E, Koukoulis G, et al. Superoxide dismutase activity in children with chronic liver diseases. J Hepatol. 2000;32:188-192.
42. Choung BY, Byun SJ, Suh JG, et al. Extracellular superoxide dismutase tissue distribution and the patterns of superoxide dismutase mRNA expression following ultraviolet irradiation on mouse skin. Exp Dermatol. 2004;13:691-699.
43. Kassab-Chekir A, Laradi S, Ferchichi S, et al. Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta. 2003;338:79-86.
44. Bahcecioglu IH, Yalniz M, Ilhan N, et al. Levels of serum vitamin A, alpha-tocopherol and malondialdehyde in patients with non-alcoholic steatohepatitis: relationship with histopathologic severity. Int J Clin Pract. 2005;59:318-323.
45. Bonnefont-Rousselot D, Ratziu V, Giral P, et al, for the LIDO study group. Blood oxidative stress markers are unreliable markers of hepatic steatosis. Aliment Pharmacol Ther. 2006;23:91-98.
46. Perlemuter G, Davit-Spraul A, Cosson C, et al. Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease. Liver Int. 2005;25:946-953.